A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00076401 · TERMINATED
Trial details
- NCT number
- NCT00076401
- Sponsor
- Pharmacyclics LLC.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.